isradipine, (s)-isomer has been researched along with norethindrone in 1 studies
| Studies (isradipine, (s)-isomer) | Trials (isradipine, (s)-isomer) | Recent Studies (post-2010) (isradipine, (s)-isomer) | Studies (norethindrone) | Trials (norethindrone) | Recent Studies (post-2010) (norethindrone) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 4,295 | 884 | 303 |
| Protein | Taxonomy | isradipine, (s)-isomer (IC50) | norethindrone (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.808 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.433 | |
| Progesterone receptor | Homo sapiens (human) | 0.0032 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.433 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.0711 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.433 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 4.537 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
1 other study(ies) available for isradipine, (s)-isomer and norethindrone
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |